Tetrahydro-pyridoazepin-8-ones and related compounds for the treatment of schizophrenia

Details for Australian Patent Application No. 2006228426 (hide)

Owner Warner-Lambert Company LLC

Inventors White, Andrew David; Favor, David Alan; Repine, Joseph Thomas; Johnson, Douglas Scott

Agent Allens Arthur Robinson

Pub. Number AU-A-2006228426

PCT Pub. Number WO2006/103559

Priority 60/667,447 01.04.05 US

Filing date 20 March 2006

Wipo publication date 5 October 2006

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61K 31/551 (2006.01) - having two nitrogens as ring hetero atoms, e.g. clozapine, dilazep

Event Publications

27 September 2007 PCT application entered the National Phase

  PCT publication WO2006/103559 Priority application(s): WO2006/103559

25 March 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006228435-New class of gammadelta T cells activators and use thereof

2006228424-DSL state and line profile control